ArticleNature2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Robert T Manguso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
718 papers cite itlatest 60 shown
this papercites it
ArticleNature2017
Robert T Manguso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.